Loading…
Loading…
MCK · NYSE · Healthcare
“With a P/E exceeding 26, McKesson's current valuation appears to offer insufficient margin of safety despite its steady pharmaceutical distribution earnings profile.”
— In the voice of Graham
Analyze dividend yield, payout ratio, growth history, and sustainability for income-oriented investment decisions.
Market Cap
$113.60B
P/E Ratio
26.17
Forward P/E
—
EPS
$9.63
PEG Ratio
0.69
Book Value
$-10.54
Dividend Yield
0.09%
Profit Margin
1.12%
ROE
—
Use the interactive dividend analyzer with pre-loaded data for Mckesson Corporation. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for MCK: